C. Blonski

发表

Synthesis and evaluation of new phosphonolipid compounds for gene delivery.

P. Hoffmann, Angélique Durand Dal-Maso, J. Dellacasagrande, 2008, European journal of medicinal chemistry.

Spermidinyl-CoA-based HAT inhibitors block DNA repair and provide cancer- specific chemo-and radiosensitization

C. Blonski, J. Banères, R. Gjerset, 2009, Cell cycle.

RNase H-mediated inhibition of translation by antisense oligodeoxyribonucleotides: use of backbone modification to improve specificity.

J. Toulmé, C. Blonski, D. Shire, 1992, Gene.

Glycolysis and proteases as targets for the design of new anti-trypanosome drugs.

J. Périé, P. Michels, C. Blonski, 2002, Current topics in medicinal chemistry.

Synthesis and application of a N-1' fluorescent biotinyl derivative inducing the specific carboxy-terminal dual labeling of a novel RhoB-selective scFv.

G. Favre, J. Faye, C. Blonski, 2009, Bioconjugate chemistry.

Characterization and sequencing of normal and modified oligonucleotides by 252Cf plasma desorption mass spectrometry.

A. Viari, P. Vigny, C. Blonski, 1988, Biomedical & environmental mass spectrometry.

Plasma desorption mass spectrometric analysis of oligonucleoside methylphosphonates

A. Viari, P. Vigny, C. Blonski, 1987 .

Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.

R. Krauth-Siegel, C. Blonski, P. Loiseau, 2017, Bioorganic & medicinal chemistry.

Slow-binding inhibition of 2-keto-3-deoxy-6-phosphogluconate (KDPG) aldolase.

L. Hecquet, C. Blonski, Rémi Braga, 2004, Bioorganic & medicinal chemistry.

Interaction of substituted hexose analogues with the Trypanosoma brucei hexose transporter.

F. Opperdoes, M. Barrett, J. Périé, 2004, Biochemical pharmacology.

1,1-Bis-(4-methoxyphenyl)-1′-pyrenyl methyl (bmpm): a new fluorescent 5′ protecting group for the purification of unmodified and modified oligonucleotides

C. Blonski, D. Shire, J. Fourrey, 1987 .

Bismuth triflate-catalyzed oxa- and thia-Pictet–Spengler reactions: access to iso- and isothio-chroman compounds

P. Hoffmann, C. Blonski, C. Lherbet, 2008 .

Bismuth(III) Triflate: A Safe and Easily Handled Precursor for Triflic Acid: Application to the Esterification Reaction

C. Blonski, C. Lherbet, Cécile Baudoin-Dehoux, 2010 .

Synthesis of phosphono analogues of dihydroxyacetone phosphate and glyceraldehyde 3-phosphate.

J. Périé, C. Blonski, P. Page, 1999, Bioorganic & medicinal chemistry.

Selective irreversible inhibition of fructose 1,6-bisphosphate aldolase from Trypanosoma brucei.

N. Chabot, P. Michels, J. Sygusch, 2006, Journal of medicinal chemistry.

An improved synthesis of phosphonomethyl analogues of glyceraldehyde- 3-phosphate and dihydroxy-acetone phosphate

J. Périé, C. Blonski, P. Page, 1995 .

‘O-phosphobiotine analogues.’ Isolation, X-ray strurcture, and reactivity of the intermediate of the addition of hindered phosphuric esters and thioesters on the carbodi-imide group. O → N phosphoryl migration versus P–O–P bond formation

G. Germain, C. Blonski, J. Declercq, 1982 .

Irreversible inhibition of aldolase by a phosphorylated α-dicarbonyl compound

P. Hoffmann, N. Chabot, T. Gefflaut, 2008 .

In vitro inhibitory effects of palmatine from Enantia chlorantha on Trypanosoma cruzi and Leishmania infantum

C. Blonski, B. Schneider, B. Nyassé, 2009, Natural product research.

Antitrypanosomal alkaloids from Polyalthia suaveolens (Annonaceae): their effects on three selected glycolytic enzymes of Trypanosoma brucei.

V. Hannaert, C. Blonski, B. Schneider, 2010, Bioorganic & medicinal chemistry letters.

Hydroxynaphthaldehyde phosphate derivatives as potent covalent Schiff base inhibitors of fructose-1,6-bisphosphate aldolase.

J. Sygusch, C. Blonski, M. Coinçon, 2005, Biochemistry.

Structural flexibility in Trypanosoma brucei enolase revealed by X‐ray crystallography and molecular dynamics

D. Rigden, L. Mello, M. Navarro, 2007, The FEBS journal.

Enzymatic synthesis of amino acid ester of butyl α-D-glucopyranoside

J. Périé, P. Monsan, C. Blonski, 1994 .

New Potent Bisubstrate Inhibitors of Histone Acetyltransferase p300: Design, Synthesis and Biological Evaluation

P. Hoffmann, C. Blonski, M. Maturano, 2011, Chemical biology & drug design.

Cell permeation of a Trypanosoma brucei aldolase inhibitor: evaluation of different enzyme-labile phosphate protecting groups.

L. Azéma, C. Blonski, C. Lherbet, 2006, Bioorganic & medicinal chemistry letters.

Antisense effect of oligodeoxynucleotides complementary to the mini-exon sequence of the protozoan parasite Leishmania amazonensis.

J. Toulmé, C. Blonski, D. Shire, 1993, Biochimie.

Chemical and enzymatic synthesis of fructose analogues as probes for import studies by the hexose transporter in parasites.

F. Bringaud, L. Azéma, C. Blonski, 2000, Bioorganic & medicinal chemistry.

Glycolysis as a target for the design of new anti-trypanosome drugs.

C L Verlinde, F. Opperdoes, M. Gelb, 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Inhibition of the glycolytic enzymes in the trypanosome: an approach in the development of new leads in the therapy of parasitic diseases.

F. Opperdoes, M. Callens, T. Gefflaut, 1993, Pharmacology & therapeutics.

Fragmentation and rearrangement patterns of phospho‐ureas. Possible consequences for biotin activation

J. Périé, C. Blonski, A. Klaébé, 1989 .

Biomimetic study of intramolecular phosphoryl group transfer in thioureas under acid/base and stereoelectronic control

C. Blonski, A. F. Hegarty, A. Klaébé, 1984 .

N-Sulfonyl hydroxamate derivatives as inhibitors of class II fructose-1,6-diphosphate aldolase.

C. Blonski, A. Vigroux, C. Dax, 2005, Bioorganic & medicinal chemistry letters.

Class I aldolases: substrate specificity, mechanism, inhibitors and structural aspects.

J. Périé, T. Gefflaut, C. Blonski, 1995, Progress in biophysics and molecular biology.

Inhibition of rabbit muscle aldolase by phosphorylated aromatic compounds.

J. Sygusch, C. Blonski, J. Périé, 1997, The Biochemical journal.

Origin of the Slow‐Binding Inhibition of Aldolase by D‐glycero‐Tetrulose 1‐Phosphate (D‐Erythrulose 1‐Phosphate) from the Comparison with the Isosteric Phosphonate Analog

J. Périé, C. Blonski, P. Page, 1999 .

Oxygen-regulated in vitro transcription of Rhizobium meliloti nifA and fixK genes

C. Blonski, J. Batut, P. Boistard, 1993, Journal of bacteriology.

The N-phosphobiotin route: a possible new pathway for biotin coenzyme

C. Blonski, A. Klaébé, J. Périé, 1987 .

Slow reversible inhibitions of rabbit muscle aldolase with substrate analogues: synthesis, enzymatic kinetics and UV difference spectroscopy studies.

T. Gefflaut, C. Blonski, J. Périé, 1996, Bioorganic & medicinal chemistry.

Characterization of proton abstraction steps in enzymatic reactions by Fourier transform infrared spectroscopy.

L. Azéma, J. Sygusch, C. Blonski, 2003, Analytical biochemistry.

An improved chemical and enzymatic synthesis of new fructose derivatives for import studies by the glucose transporter in parasites

J. Périé, C. Blonski, P. Page, 1996 .

Design, synthesis and in vitro antikinetoplastid evaluation of N-acylated putrescine, spermidine and spermine derivatives.

C. Blonski, P. Loiseau, S. Pèthe, 2015, Bioorganic & medicinal chemistry letters.